Immunogenic cell death (ICD) is emerging as a key component of antitumor therapy that harnesses the immune system of the patient to combat cancer. In recent years, several efforts were made to improve the ICD-based therapies. Here, we discuss how nanomaterial-based strategies increase the efficacy of ICD and highlight their benefits and challenges.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.trecan.2024.03.003 | DOI Listing |
Publication Analysis
Top Keywords
immunogenic cell
8
cell death
8
nanomedicine aid
4
aid immunogenic
4
death icd-based
4
icd-based anticancer
4
anticancer therapy
4
therapy immunogenic
4
death icd
4
icd emerging
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!